Back

Watch Compare

Jin Medical International Ltd.

Data quality: 100%

ZJYL

Nasdaq Manufacturing Measuring & Analyzing Instruments

$2.24

▲ $0.04 (1.82%)

Mkt Cap: 17.53 M

Price

$2.24

Mkt Cap

17.53 M

Day Range

$2.10 — $2.28

52-Week Range

$1.64 — $19.70

Volume

5,855

Open $2.21

50D / 200D Avg

$2.61

14.04% below

50D / 200D Avg

$7.43

69.83% below

Quick Summary

Key Takeaways

Earnings declined -67.59% over the past year

ROE of 4.40% is below average

Negative free cash flow of -3.73 M

P/E of 14.72 — trading at a low valuation

Capital intensive — 32.05% of revenue goes to capex

ROIC of 1.32% — low return on invested capital

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)-11.98%

Earnings (1Y)-67.59%

FCF Growth (3Y)N/A

Quality

Return on Equity

4.40%

Above sector avg (-53.41%)

ROIC1.32%

Net Margin5.76%

Op. Margin2.94%

Safety

Debt / Equity

0.56

Above sector avg (0.31)

Current Ratio2.11

Interest CoverageN/A

Valuation

PE (TTM)

14.72

Above sector avg (-1.48)

P/B Ratio0.63

EV/EBITDA39.06

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	14.7	-1.5
P/B	0.6	1.6
ROE %	4.4	-53.4
Net Margin %	5.8	-41.5
Rev Growth 5Y %	—	1.8
D/E	0.6	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-11.98%	Revenue Growth (3Y)	2.16%
Earnings Growth (1Y)	-67.59%	Earnings Growth (3Y)	-35.67%
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	20.69 M	Net Income (TTM)	1.19 M
ROE	4.40%	ROA	2.66%
Gross Margin	29.22%	Operating Margin	2.94%
Net Margin	5.76%	Free Cash Flow (TTM)	-3.73 M
ROIC	1.32%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0.56	Current Ratio	2.11
Interest Coverage	N/A	Asset Turnover	0.46
Working Capital	23.04 M	Tangible Book Value	26.82 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	14.72	Forward P/E	N/A
P/B Ratio	0.63	P/S Ratio	0.85
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	39.06	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-21.25%
Market Cap	17.53 M	Enterprise Value	33.26 M
Per Share
EPS (Diluted TTM)	0.01	Revenue / Share	2.64
FCF / Share	-0.48	OCF / Share	0.37
EPS CAGR (1Y)	-50.00%	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	32.05%	FCF Conversion	-312.79%
SBC-Adj. FCF	N/A	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023
Revenue	20.69 M	23.50 M	19.82 M
Net Income	1.19 M	3.68 M	2.88 M
EPS (Diluted)	0.01	0.02	0.02
Gross Profit	6.04 M	9.50 M	6.78 M
Operating Income	608,182.0	3.64 M	2.87 M
EBITDA	—	—	—
R&D Expenses	1.56 M	1.50 M	1.54 M
SG&A Expenses	—	—	—
D&A	243,403.0	237,823.0	225,902.0
Interest Expense	—	—	182,682.0
Income Tax	214,572.0	763,879.0	343,707.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023
Total Assets	53.37 M	45.80 M	32.90 M
Total Liabilities	23.80 M	17.25 M	8.92 M
Shareholders' Equity	29.64 M	28.82 M	23.98 M
Total Debt	18.84 M	11.32 M	—
Cash & Equivalents	—	—	—
Current Assets	44.14 M	42.82 M	31.12 M
Current Liabilities	23.80 M	17.15 M	8.92 M